Phase III, Multicenter, Randomized, Double-Blind, Placebo- Controlled Parallel-Designed Evaluation to Assess Safety and Efficacy of Topical Benzocaine for Treatment of Pain Associated With Acute Otitis Media in Children Ages 5 to 12 Years
The Phase III study is designed to assess the safety, tolerability, and efficacy of Topical Benzocaine in children, ages 5 to 12 years, presenting with Acute Otitis Media-associated ear pain.
100 Clinical Results associated with Lachlan Pharma Holdings Unlimited Co.
0 Patents (Medical) associated with Lachlan Pharma Holdings Unlimited Co.
100 Deals associated with Lachlan Pharma Holdings Unlimited Co.
100 Translational Medicine associated with Lachlan Pharma Holdings Unlimited Co.